Synonyms: PBS-105 | PBS105
tuvonralimab is an approved drug
Compound class:
Antibody
Comment: Tuvonralimab (PBS105) is a humanized monoclonal antibody that targets the immune checkpoint protein, cytotoxic T-lymphocyte-associated protein 4 (CTLA4). It stimulates antitumour immunity.
|
Classification ![]() |
|
Compound class | Antibody |
Approved drug? | Yes. China NMPA (2024) |
International Nonproprietary Names ![]() |
|
INN number | INN |
11841 | tuvonralimab |
Synonyms ![]() |
PBS-105 | PBS105 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 1204 |
Other databases | |
GtoPdb PubChem SID | 507750426 |
Search PubMed clinical trials | tuvonralimab |
Search PubMed titles | tuvonralimab |
Search PubMed titles/abstracts | tuvonralimab |